Sinopharm Tech Holdings (HKSE:08156) Other Financing: HK$-0.84 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08156 Sinopharm Tech Holdings Ltd HKSE:08156
27 GF Score
Price HK$0.16
GF Value HK$0.06
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sinopharm Tech Holdings Other Financing?

Sinopharm Tech Holdings HKSE:08156 -2.50% 27 Other Financing is HK$-0.84 Mil as of Dec. 2025. GuruFocus rates HKSE:08156 with a GF Score™ of 27/100 and a GF Value™ of HK$0.06 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Sinopharm Tech Holdings's Other Financing for the six months ended in Dec. 2025 was HK$-0.05 Mil.

Sinopharm Tech Holdings's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.84 Mil.

Sinopharm Tech Holdings Other Financing Historical Data

* Premium members only.

The historical data trend for Sinopharm Tech Holdings's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopharm Tech Holdings Other Financing Chart

Sinopharm Tech Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.40 -2.48 -3.50 -0.02 -1.51

Sinopharm Tech Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.02 -1.51 -0.79 -0.05
HKSE:08156
27GF Score
Sinopharm Tech Holdings Ltd HKSE:08156
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinopharm Tech Holdings Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of HK$-0.84 Mil mean?
Sinopharm Tech Holdings (HKSE:08156) has a Other Financing of HK$-0.84 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sinopharm Tech Holdings and its competitors.
Is Sinopharm Tech Holdings' Other Financing too high?
Sinopharm Tech Holdings' current Other Financing is HK$-0.84 Mil. Overall, Sinopharm Tech Holdings has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Tech Holdings' Other Financing compare to QH and SHOP?
Sinopharm Tech Holdings' Other Financing of HK$-0.84 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Software company?
A good Other Financing depends on the Software industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sinopharm Tech Holdings and its competitors. Sinopharm Tech Holdings's current Other Financing is HK$-0.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Tech Holdings stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Tech Holdings (HKSE:08156) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.06, compared to a current price of HK$0.16 — trading 160% above its estimated fair value. The current Other Financing is HK$-0.84 Mil. Sinopharm Tech Holdings' overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Sinopharm Tech Holdings (HKSE:08156), the current Other Financing is HK$-0.84 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinopharm Tech Holdings (HKSE:08156) Overvalued in 2026?

Based on GuruFocus' analysis, Sinopharm Tech Holdings stock appears to be overvalued. The current stock price of HK$0.16 is trading 160% above its estimated GF Value™ of HK$0.06. GuruFocus considers Sinopharm Tech Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:08156:

  • Other Financing: HK$-0.84 Mil
  • GF Value™: HK$0.06 vs. price of HK$0.16 (160% above fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the HKSE:08156 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sinopharm Tech Holdings Business Description

Address Ruttonjee Centre, 11 Duddell Street Central, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company operating through three segments: Internet Plus services, Supply Chain services, and Manufacturing and distribution of personal protective equipment. The company generates the majority of its revenue from the Supply Chain services segment, which includes supply chain management, data analysis, and trading of medical and related products. Geographically, it operates in Hong Kong and the People's Republic of China (PRC), with the majority of its revenue coming from the PRC.
27GF Score

Get the complete analysis for HKSE:08156

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.16
Price
HK$0.06
GF Value